Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Newly Diagnosed Astrocytoma, Grade IV”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Looking for participantsNCT06991101
What this trial is testing

Ruxolitinib With Radiation and Temozolomide Compared to Radiation and Temozolomide for Newly Diagnosed Glioblastoma

Who this might be right for
GlioblastomaBrain CancerGlioblastoma Multiforme+4 more
Baptist Health South Florida 190
Testing effectiveness (Phase 2)Study completedNCT00944801
What this trial is testing

Pegylated Liposomal Doxorubicine and Prolonged Temozolomide in Addition to Radiotherapy in Newly Diagnosed Glioblastoma

Who this might be right for
Glioblastoma
University of Regensburg 63
Testing effectiveness (Phase 2)Active Not RecruitingNCT02331498
What this trial is testing

Phase I/II Study of Pazopanib+ Temozolomide in Patients With Newly Diagnosed Glioblastoma Multiforme

Who this might be right for
Glioblastoma Multiforme
Centre Antoine Lacassagne 51
Testing effectiveness (Phase 2)Study completedNCT00813943
What this trial is testing

Cilengitide, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma and Unmethylated Gene Promoter Status

Who this might be right for
Glioblastoma
EMD Serono 265
Early research (Phase 1)Study completedNCT00792012
What this trial is testing

A Dose Per Fraction Escalation Trial of Hypofractionated IMRT With Temozolomide for Newly Diagnosed Glioblastoma

Who this might be right for
Glioblastoma Multiforme
University of Colorado, Denver 37
Early research (Phase 1)Study completedNCT03576612
What this trial is testing

GMCI, Nivolumab, and Radiation Therapy in Treating Patients With Newly Diagnosed High-Grade Gliomas

Who this might be right for
Glioma, Malignant
Candel Therapeutics, Inc. 41
Large-scale testing (Phase 3)UnknownNCT01656980
What this trial is testing

Safety and Efficacy Study of Intracranially Implanted Carmustine to Treat Newly Diagnosed Malignant Glioma

Who this might be right for
Anaplastic AstrocytomaAnaplastic OligodendrogliomaAnaplastic Oligoastrocytoma+1 more
Shandong Lanjin Pharmaceuticals Co.,Ltd 236
Not applicableUnknownNCT02520635
What this trial is testing

Supra-early Post-Surgery Chemotherapy in the Treatment on GBM Patients

Who this might be right for
Glioblastoma
Beijing Tiantan Hospital 180
Testing effectiveness (Phase 2)Study completedNCT03367715
What this trial is testing

Nivolumab, Ipilimumab, and Short-course Radiotherapy in Adults With Newly Diagnosed, MGMT Unmethylated Glioblastoma

Who this might be right for
MGMT-unmethylated Glioblastoma (GBM)GBM
NYU Langone Health 10
Early research (Phase 1)WithdrawnNCT04741984
What this trial is testing

Monocyte Antigen Carrier Cells for Newly Diagnosed GBM

Who this might be right for
GlioblastomaGlioma, Malignant
Michael Gunn
Early research (Phase 1)Study completedNCT06095375
What this trial is testing

Regorafenib With Temozolomide With or Without RT in MGMT-Methylated, IDH Wild-type GBM Patients

Who this might be right for
Glioblastoma, IDH-wildtypeMGMT-Methylated Glioblastoma
Istituto Oncologico Veneto IRCCS 21
Early research (Phase 1)Active Not RecruitingNCT04047706
What this trial is testing

Nivolumab, BMS-986205, and Radiation Therapy With or Without Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma

Who this might be right for
Glioblastoma
Northwestern University 18
Not applicableWithdrawnNCT02194452
What this trial is testing

Efficacy of 68Ga-DOTATOC Positron Emission Tomography (PET) CT in Children and Young Adults With Brain Tumors

Who this might be right for
Acoustic SchwannomaAdult Anaplastic AstrocytomaAdult Anaplastic Ependymoma+92 more
Sue O'Dorisio
Testing effectiveness (Phase 2)Looking for participantsNCT05664464
What this trial is testing

Glutamate Inhibitors in Glioblastoma

Who this might be right for
Glioblastoma
University of Zurich 120
Early research (Phase 1)Study completedNCT05698199
What this trial is testing

Study to Evaluate the Safety, Tolerability, Immunogenicity and Preliminary Efficacy of ITI-1001 In Patients With Newly Diagnosed Glioblastoma (GBM)

Who this might be right for
Glioblastoma
Immunomic Therapeutics, Inc. 10
Early research (Phase 1)Ended earlyNCT04963413
What this trial is testing

RENEW: Feasibility of CMV RNA-Pulsed Dendritic Cells Vaccines for the Treatment of Newly Diagnosed Glioblastoma Patients.

Who this might be right for
Glioblastoma
University of Florida 6
Testing effectiveness (Phase 2)UnknownNCT04583020
What this trial is testing

Neoadjuvant PD-1 in Newly Diagnosed Glioblastoma

Who this might be right for
Glioblastoma
Peking Union Medical College Hospital 42
Large-scale testing (Phase 3)UnknownNCT00003788
What this trial is testing

Surgery, Radiation Therapy, and Chemotherapy With or Without Photodynamic Therapy in Treating Patients With Newly Diagnosed or Recurrent Malignant Supratentorial Gliomas

Who this might be right for
Brain and Central Nervous System Tumors
Colorado Health Foundation 270
Early research (Phase 1)Study completedNCT00006474
What this trial is testing

Temozolomide and O6-benzylguanine in Treating Patients With Newly Diagnosed, Recurrent, or Progressive Anaplastic Glioma

Who this might be right for
Brain and Central Nervous System Tumors
Duke University
Testing effectiveness (Phase 2)UnknownNCT05163080
What this trial is testing

SurVaxM Plus Adjuvant Temozolomide for Newly Diagnosed Glioblastoma (SURVIVE)

Who this might be right for
Newly Diagnosed Glioblastoma
MimiVax, LLC 247
Next Page